The 5th Edition of the WHO Classification of CNS Tumours [1] introduced CRINET as a provisional diagnosis; it is a non‐rhabdoid neuroectodermal tumor with a prominent cribriform arrangement of tumor cells that have characteristic loss of INI1 due to homozygous loss‐of‐function of SMARCB1. This evidence concerns the gene SMARCB1 and central nervous system neoplasm.